Cytena was founded in 2014 and develops advanced single-cell printing technology used in cell research and professional diagnostics. Its innovative solutions enable scientists to isolate and handle individual cells with high precision, improving efficiency and accuracy in applications such as cell line development, biotechnology, and medical research. By combining automation with cutting-edge technology, Cytena helps accelerate discoveries and streamline workflows in modern life sciences.